 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1lrt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Crystal structure of ternary complex of tritrichomonas foetus inosine-5'-monophosphate dehydrogenase: structural characterization of NAD+ site in microbial enzyme
|
|
Structure:
|
 |
Inosine-5'-monophosphate dehydrogenase. Chain: a, b, c, d. Synonym: inosine-5'-monophosphate dehydrogenase, imp dehydrogenase, impdh, impd. Engineered: yes
|
|
Source:
|
 |
Tritrichomonas foetus. Organism_taxid: 5724. Gene: impdh. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
2.20Å
|
R-factor:
|
0.212
|
R-free:
|
0.246
|
|
|
Authors:
|
 |
L.Gan,G.A.Petsko,L.Hedstrom
|
Key ref:
|
 |
L.Gan
et al.
(2002).
Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis.
Biochemistry,
41,
13309-13317.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
15-May-02
|
Release date:
|
07-Jul-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P50097
(IMDH_TRIFO) -
Inosine-5'-monophosphate dehydrogenase
|
|
|
|
Seq: Struc:
|
 |
 |
 |
503 a.a.
338 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.1.1.205
- Imp dehydrogenase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
AMP and GMP Biosynthesis
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Inosine 5'-phosphate + NAD+ + H2O = xanthosine 5'-phosphate + NADH
|
 |
 |
 |
 |
 |
Inosine 5'-phosphate
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
NAD(+)
|
+
|
H(2)O
|
=
|
xanthosine 5'-phosphate
|
+
|
NADH
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
metabolic process
|
2 terms
|
 |
|
Biochemical function
|
catalytic activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
41:13309-13317
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis.
|
|
L.Gan,
G.A.Petsko,
L.Hedstrom.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Inosine 5'-monophosphate dehydrogenase (IMPDH) catalyzes the conversion of IMP
to XMP with the reduction of NAD(+), which is the rate-limiting step in the
biosynthesis of guanine nucleotides. IMPDH is a promising target for
chemotherapy. Microbial IMPDHs differ from mammalian enzymes in their lower
affinity for inhibitors such as mycophenolic acid (MPA) and
thiazole-4-carboxamide adenine dinucleotide (TAD). Part of this resistance is
determined by the coupling between nicotinamide and adenosine subsites in the
NAD(+) binding site that is postulated to involve an active site flap. To
understand the structural basis of the drug selectivity, we solved the X-ray
crystal structure of the catalytic core domain of Tritrichomonas foetus IMPDH in
complex with IMP and beta-methylene-TAD at 2.2 A resolution. Unlike previous
structures of this enzyme, the active site loop is ordered in this complex, and
the catalytic Cys319 is 3.6 A from IMP, in the same plane as the hypoxanthine
ring. The active site loop forms hydrogen bonds to the carboxamide of
beta-Me-TAD which suggests that NAD(+) promotes the nucleophillic attack of
Cys319 on IMP. The interactions of the adenosine end of TAD are very different
from those in the human enzyme, suggesting the NAD(+) site may be an exploitable
target for the design of antimicrobial drugs. In addition, a new K(+) site is
observed at the subunit interface. This site is adjacent to beta-Me-TAD,
consistent with the link between the K(+) activation and NAD(+). However,
contrary to the coupling model, the flap does not cover the adenosine subsite
and remains largely disordered.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.R.Gollapalli,
I.S.Macpherson,
G.Liechti,
S.K.Gorla,
J.B.Goldberg,
and
L.Hedstrom
(2010).
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
|
| |
Chem Biol, 17,
1084-1091.
|
 |
|
|
|
|
 |
L.Hedstrom
(2009).
IMP dehydrogenase: structure, mechanism, and inhibition.
|
| |
Chem Rev, 109,
2903-2928.
|
 |
|
|
|
|
 |
M.Pimkin,
J.Pimkina,
and
G.D.Markham
(2009).
A Regulatory Role of the Bateman Domain of IMP Dehydrogenase in Adenylate Nucleotide Biosynthesis.
|
| |
J Biol Chem, 284,
7960-7969.
|
 |
|
|
|
|
 |
S.Das,
A.Kokardekar,
and
C.M.Breneman
(2009).
Rapid comparison of protein binding site surfaces with property encoded shape distributions.
|
| |
J Chem Inf Model, 49,
2863-2872.
|
 |
|
|
|
|
 |
D.Xu,
G.Cobb,
C.J.Spellicy,
S.J.Bowne,
S.P.Daiger,
and
L.Hedstrom
(2008).
Retinal isoforms of inosine 5'-monophosphate dehydrogenase type 1 are poor nucleic acid binding proteins.
|
| |
Arch Biochem Biophys, 472,
100-104.
|
 |
|
|
|
|
 |
M.Pimkin,
and
G.D.Markham
(2008).
The CBS subdomain of inosine 5'-monophosphate dehydrogenase regulates purine nucleotide turnover.
|
| |
Mol Microbiol, 68,
342-359.
|
 |
|
|
|
|
 |
Q.Shu,
and
V.Nair
(2008).
Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
|
| |
Med Res Rev, 28,
219-232.
|
 |
|
|
|
|
 |
S.E.Mortimer,
D.Xu,
D.McGrew,
N.Hamaguchi,
H.C.Lim,
S.J.Bowne,
S.P.Daiger,
and
L.Hedstrom
(2008).
IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA.
|
| |
J Biol Chem, 283,
36354-36360.
|
 |
|
|
|
|
 |
T.V.Riera,
W.Wang,
H.R.Josephine,
and
L.Hedstrom
(2008).
A kinetic alignment of orthologous inosine-5'-monophosphate dehydrogenases.
|
| |
Biochemistry, 47,
8689-8696.
|
 |
|
|
|
|
 |
B.OuYang,
S.S.Pochapsky,
G.M.Pagani,
and
T.C.Pochapsky
(2006).
Specific effects of potassium ion binding on wild-type and L358P cytochrome P450cam.
|
| |
Biochemistry, 45,
14379-14388.
|
 |
|
|
|
|
 |
E.Di Cera
(2006).
A structural perspective on enzymes activated by monovalent cations.
|
| |
J Biol Chem, 281,
1305-1308.
|
 |
|
|
|
|
 |
W.J.Sullivan,
S.E.Dixon,
C.Li,
B.Striepen,
and
S.F.Queener
(2005).
IMP dehydrogenase from the protozoan parasite Toxoplasma gondii.
|
| |
Antimicrob Agents Chemother, 49,
2172-2179.
|
 |
|
|
|
|
 |
N.N.Umejiego,
C.Li,
T.Riera,
L.Hedstrom,
and
B.Striepen
(2004).
Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.
|
| |
J Biol Chem, 279,
40320-40327.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|